Showing results (121-130 of 196) with videos related to

Sort By:
Pageof 20
Plos One|March 4, 2014
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cellsMaria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, et al.
Oncotarget|March 13, 2013
In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myelomaMaria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, et al.
Critical Reviews in Oncology/Hematology|December 8, 2023
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysisNicoletta Staropoli, Domenico Ciliberto, Francesco Luciano, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative PropertiesRoberta Rocca, Francesca Scionti, Matteo Nadai, et al.
ACS Omega|December 7, 2020
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome ProfilingMario Russo, Luca Tirinato, Francesca Scionti, et al.
Clinical Pharmacology and Therapeutics|February 11, 2019
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control StudyMariamena Arbitrio, Francesca Scionti, Emanuela Altomare, et al.
Cell Cycle (Georgetown, Tex.)|October 5, 2013
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cellsNicola Amodio, Dina Bellizzi, Marzia Leotta, et al.
Basic Research in Cardiology|September 3, 2024
Immuno-related cardio-vascular adverse events associated with immuno-oncological treatments: an under-estimated threat for cancer patientsGiuseppe Panuccio, Pierpaolo Correale, Maria d'Apolito, et al.
Pageof 20